U.S. Markets open in 9 hrs 11 mins

Gilead Sciences, Inc. :GILD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

CapitalCube
Capital Cube
Gilead Sciences, Inc. :GILD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

Categories: Yahoo FinanceGet free summary analysis Gilead Sciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Gilead Sciences, Inc. – Amgen Inc., Vertex Pharmaceuticals Incorporated, Celgene Corporation, Alexion Pharmaceuticals, Inc., AbbVie, Inc., Illumina, Inc., Biogen Inc., Eli Lilly and Company, Merck & Co., Inc. ... Read more (Read more...)